Treatable causes of cerebellar ataxia

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Movement Disorders

• Publication date

  2015-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mds.26158PMID 25757427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

  2014cited by this paper
• Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management

  2014cited by this paper
• Agranulocytosis with deferiprone treatment of superficial siderosis

  2013cited by this paper
• Good outcome in patients with early dietary treatment of GLUT‐1 deficiency syndrome: results from a retrospective Norwegian study

  2013cited by this paper
• Transglutaminase 6 antibodies in the diagnosis of gluten ataxia

  2013cited by this paper
• Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review.

  2013cited by this paper
• Consensus Paper: Management of Degenerative Cerebellar Disorders

  2013cited by this paper
• Neurological Outcome in Cerebrotendinous Xanthomatosis Treated With Chenodeoxycholic Acid: Early Versus Late Diagnosis

  2013cited by this paper
• Treatment of superficial siderosis with iron chelation therapy

  2013cited by this paper
• Treatment of Paraneoplastic Cerebellar Degeneration

  2013cited by this paper
• Cerebrotendinous xanthomatosis--the spectrum of imaging findings.

  2013cited by this paper
• Heterogeneity and frequency of movement disorders in juvenile and adult-onset Niemann-Pick C disease

  2013cited by this paper
• Miglustat: A Review of Its Use in Niemann-Pick Disease Type C

  2013cited by this paper
• Update on a Patient with Superficial Siderosis on Deferiprone

  2012cited by this paper
• Long‐term strategies for the treatment of Refsum's disease using therapeutic apheresis

  2012cited by this paper
• Hashimoto’s Encephalopathy as a Treatable Adult-Onset Cerebellar Ataxia Mimicking Spinocerebellar Degeneration

  2012cited by this paper
• Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study

  2012cited by this paper
• Episodic ataxias 1 and 2.

  2012cited by this paper
• Heterogeneity of coenzyme Q10 deficiency: patient study and literature review.

  2012influential reference
• Glut1 deficiency syndrome and erythrocyte glucose uptake assay

  2011cited by this paper
• A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias

  2011cited by this paper
• Niemann‐Pick type C disease: molecular mechanisms and potential therapeutic approaches

  2011influential reference
• Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration

  2011cited by this paper
• Gluten sensitivity: from gut to brain

  2011cited by this paper
• Hashimoto’s encephalopathy mimicking spinocerebellar ataxia

  2011cited by this paper
• Acquired progressive ataxia and palatal tremor: importance of MRI evidence of hemosiderin deposition and vascular malformations.

  2011cited by this paper
• Sporadic ataxia with adult onset: classification and diagnostic criteria.

  2010cited by this paper
• Coenzyme Q10‐responsive ataxia: 2‐year‐treatment follow‐up

  2010cited by this paper
• Gluten sensitivity: from gut to brain.

  2010cited by this paper
• The spectrum of movement disorders in Glut‐1 deficiency

  2010cited by this paper
• Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers

  2010cited by this paper
• Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.

  2010cited by this paper
• Niemann-Pick disease type C

  2010cited by this paper
• Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.

  2010cited by this paper
• Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C

  2010cited by this paper
• Frequency, characteristics, and risk factors for amiodarone neurotoxicity.

  2009cited by this paper
• Hashimoto encephalopathy presenting with progressive cerebellar ataxia

  2009cited by this paper
• Recommendations on the diagnosis and management of Niemann-Pick disease type C.

  2009cited by this paper
• Successful treatment of paraneoplastic cerebellar degeneration with Rituximab

  2008cited by this paper
• Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

  2008cited by this paper
• CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures.

  2008cited by this paper
• Primary episodic ataxias: diagnosis, pathogenesis and treatment.

  2007cited by this paper
• Hashimoto’s encephalopathy presenting with progressive cerebellar ataxia

  2007cited by this paper
• Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study.

  2007cited by this paper
• An approach to the patient with late-onset cerebellar ataxia

  2006cited by this paper
• The adult form of Niemann-Pick disease type C.

  2006cited by this paper
• Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia

  2006cited by this paper
• Neurologic Improvement after High-dose Intravenous Immunoglobulin Therapy in Patients with Paraneoplastic Cerebellar Degeneration Associated with Anti-Purkinje Cell Antibody

  2006cited by this paper
• Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized.

  2005cited by this paper
• Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy.

  2005cited by this paper
• Amphiphysin autoimmunity: Paraneoplastic accompaniments

  2005cited by this paper
• Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine

  2004cited by this paper
• Clinical spectrum of episodic ataxia type 2

  2004cited by this paper
• Cerebellar volume and long-term use of phenytoin.

  2003cited by this paper
• Membrane differential filtration is safe and effective for the long-term treatment of Refsum syndrome--an update of treatment modalities and pathophysiological cognition.

  2003cited by this paper
• Dietary treatment of gluten ataxia

  2003cited by this paper
• Niemann–Pick disease type C

  2003cited by this paper
• Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.

  2002cited by this paper
• The aetiology of sporadic adult-onset ataxia.

  2002cited by this paper
• Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases

  2001cited by this paper
• Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

  2001cited by this paper
• Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis

  2001cited by this paper
• Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency

  2001cited by this paper
• Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease.

  2001cited by this paper
• Refsum's disease.

  2001cited by this paper
• Phytanic acid storage disease (Refsum's disease): Clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management

  1999cited by this paper
• Neurological complications of 5-fluorouracil chemotherapy: case report and review of the literature.

  1998cited by this paper
• Irreversible lithium neurotoxicity: an overview.

  1997cited by this paper
• Refsum's disease: long term treatment preserves sensory nerve action potentials and motor function.

  1997cited by this paper
• Familial episodic ataxia: Clinical heterogeneity in four families linked to chromosome 19p

  1997cited by this paper
• Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion

  1996cited by this paper
• Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p.

  1995cited by this paper
• Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein.

  1995cited by this paper
• Superficial siderosis of the central nervous system: an underdiagnosed cause of sensorineural hearing loss and ataxia.

  1994cited by this paper
• The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption

  1985cited by this paper
• Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

  1984cited by this paper
• Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management.

  1980cited by this paper

• Artificial Intelligence‐Based Virtual Assistant for the Diagnostic Approach of Chronic Ataxias

  2025cites this paper
• Peripheral Inflammation Profile of Cerebellar Ataxia

  2025cites this paper
• Rehabilitation of High-Level Dynamic Balance Skills in an Individual With Significant Nonprogressive Cerebellar Atrophy: Case Report

  2025cites this paper
• Validation of the cerebellar cognitive affective syndrome (CCAS) scale in CCAS patients and cerebellar controls

  2025cites this paper
• Protocolo diagnóstico de las ataxias

  2023cites this paper
• Utility of next-generation sequencing in the diagnosis of neurological disorders

  2023cites this paper
• Informing a value care model: lessons from an integrated adult neurogenomics clinic

  2023cites this paper
• A subtle presentation of a treatable cause of predominant hemidystonia with minimal ataxia: Expert commentary.

  2023cites this paper
• Neurodegenerative Cerebellar Ataxia

  2022cites this paper
• Therapeutic Misestimation in Patients with Degenerative Ataxia: Lessons from a Randomized Controlled Trial

  2022cites this paper
• Treatable Ataxias: How to Find the Needle in the Haystack?

  2022cites this paper
• Brain Functional Connectivity Changes in Patients with Acute Eye Pain: A Resting-State Functional Magnetic Resonance Imaging (fMRI) Study

  2021cites this paper
• Finding commonalities in rare diseases through the undiagnosed diseases network

  2021cites this paper
• Stochastic reaction-diffusion modeling of calcium dynamics in 3D dendritic spines of Purkinje cells

  2021cites this paper
• Progressive cerebellar ataxia with falsely positive anti-Ma2 antibodies

  2021cites this paper
• Primary Sjögren’s syndrome (pSS)-related cerebellar ataxia: a systematic review and meta-analysis

  2021cites this paper
• NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges

  2021cites this paper
• Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation

  2020influential citation
• A case of acute cerebellar ataxia with two possible etiologies: viral cerebellitis and paraneoplastic antibody-positive ovarian cancer

  2020cites this paper
• Influence of Vitexin on ataxia-like condition initiated by lead exposure in mice

  2020cites this paper
• Molecular basis of movement disorders

  2020cites this paper
• Lipopolysaccharide administration for a mouse model of cerebellar ataxia with neuroinflammation

  2020cites this paper
• Progressive cerebellar ataxia with falsely positive anti-Ma2 antibodies.

  2020cites this paper
• Three Adult-Onset Autosomal Recessive Ataxias: What Adult Neurologists Need to Know.

  2020cites this paper
• Newly Diagnosed

  2020cites this paper
• Influence of Vitexin on ataxia-like condition initiated by lead exposure in mice

  2020cites this paper
• Dědičné cerebelární ataxie u dospělých

  2019cites this paper
• Female sexual dysfunction associated with idiopathic cerebellar ataxia: A case report

  2019cites this paper
• Neurological gait disorders in childhood Authors

  2019cites this paper
• Hereditary cerebellar ataxias in adults

  2019cites this paper
• Cerebellar involvement in patients withprimary Sjögren’s syndrome: diagnosis and treatment

  2018cites this paper
• Parafilieën en parafiele stoornissen

  2018cites this paper
• Neurological gait disorders in childhood

  2018cites this paper
• High Degree of Genetic Heterogeneity for Hereditary Cerebellar Ataxias in Australia

  2018cites this paper
• Laboratory investigations.

  2018cites this paper
• Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma

  2017cites this paper
• Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia

  2017cites this paper
• Cerebellar ataxia with sensory ganglionopathy; does autoimmunity have a role to play?

  2017cites this paper
• Drugs in Selected Ataxias

  2016cites this paper
• Rapid Eye Movement Sleep Behavior Disorder in Paraneoplastic Cerebellar Degeneration: Improvement with Immunotherapy.

  2016cites this paper
• Current concepts in the treatment of hereditary ataxias

  2015cites this paper
• Kesknärvisüsteemi superfitsiaalne hemosideroos

  2015cites this paper